GlassScriptPhysician profile
Linda S Botello
NPI 1225173016
$3,610.06
in general payments reported to CMS, 2019-2025
12 companies · $1,611 in 2025
The $1,611 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $130 · 2021: $150 · 2022: $308 · 2023: $291 · 2024: $777 · 2025: $1,611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,678.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $973.55 | 2025 | Optilight |
| Johnson & Johnson Vision Care, INC. | $749.55 | 2019-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $433.68 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $380.12 | 2019-2025 | Precision7, Tryptyr, Total30 |
| Coopervision INC. | $310.82 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $200.73 | 2024-2025 | Miebo, Xiidra, Infuse |
| Sun Pharmaceutical Industries INC. | $148.63 | 2021-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $147.75 | 2020-2023 | |
| Abbvie INC. | $123.82 | 2022-2025 | Vuity, Lumigan |
| Allergan, INC. | $58.36 | 2019-2022 | |
| Oyster Point Pharma, INC. | $50.20 | 2022-2024 | Tyrvaya |
| Abb Con-Cise Optical Group LLC | $32.85 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Botello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.